Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on R Mandelic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1840671A details a bio-catalytic route for (R)-mandelic acid using Brevibacterium flavum. Offers high optical purity and greener manufacturing for pharmaceutical supply chains.
Patent CN106676140A reveals high-efficiency enzymatic synthesis. Offers supply chain stability and cost reduction for clopidogrel intermediates.
Advanced separation method for vanillin intermediate ensuring high purity and reduced solvent loss for reliable supply chains and cost effective manufacturing processes.
Advanced biocatalytic dynamic kinetic resolution patent CN103820521B enables high-purity pharmaceutical intermediate manufacturing with substantial cost reduction and supply reliability.
Novel chiral resolving agent enables high-purity (R)-o-chloromandelic acid production. Mature industrial route ensures supply chain stability and cost efficiency for pharmaceutical intermediates.
Patent CN100376681C details a microbial asymmetric reduction method for (R)-mandelic acid using Saccharomyces cerevisiae, offering a green, cost-effective alternative to traditional chemical resolution for pharmaceutical manufacturing.
Patent CN101709323B reveals a novel biocatalytic coupling method for R-mandelic acid production, offering superior purity and cost-effective manufacturing for pharmaceutical intermediates.
High-selectivity vanillin intermediate process reduces by-products. Cost-effective supply chain solutions for global flavor and fragrance manufacturers.
Patent CN101701222B reveals a robust enzymatic route for (R)-mandelic acid, offering superior purity and scalable manufacturing for global pharmaceutical supply chains.
Novel nitrilase enables efficient production of chiral intermediates for clopidogrel with reduced environmental impact and scalable supply chain solutions.
Novel biocatalytic method for R-mandelic acid production. High purity over 99 percent, cost-effective, scalable process for pharmaceutical supply chains.
Patent CN105505904A reveals enhanced nitrilase mutant for high-purity (R)-mandelic acid production with improved selectivity and activity for reliable supply.
Patent CN116848257A enables green production of (R)-mandelic acid. Achieve cost reduction in pharmaceutical intermediates manufacturing with sustainable enzyme cascades.
Patent CN101701243B details a high-efficiency biocatalytic route for R-mandelic acid using Alcaligenes faecalis, offering superior purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN101134943B reveals a novel Alcaligenes strain for >99.9% e.e. mandelic acid. Discover cost-effective biocatalytic solutions for pharmaceutical manufacturing.
Patented chloroform-based route for o-chloromandelic acid ensures high purity and cost reduction in API intermediate manufacturing for global supply chains.
Patent CN102660625A details enzymatic synthesis for high purity. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN101417942B reveals high-purity synthesis route. Enables cost reduction in pharma intermediate manufacturing with scalable chromatography separation.
Patent CN113354534B details a green synthesis route for D-FMC. This method ensures high purity and reduces costs for pharmaceutical intermediates manufacturing supply chains.
Patent CN105755095B details enzymatic synthesis of chiral hydroxy acids. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.